Glucocorticoid receptors are downregulated in hepatic T lymphocytes in rats with experimental cholangitis

Gut

Volumn 52, Issue 9, 2003, Pages 1363-1370

  Tjandra, K ^b   Le, T ^b   Swain, M G ^a,b  

^a Departments of Medicine and Community Health Sciences   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLANGITIS; CONTROLLED STUDY; INTRAHEPATIC CHOLESTASIS; MALE; NONHUMAN; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

1-NAPHTHYLISOTHIOCYANATE; ANIMALS; CHOLANGITIS, SCLEROSING; CHRONIC DISEASE; CORTICOSTERONE; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FLOW CYTOMETRY; INTERFERON TYPE II; INTERLEUKIN-4; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0042887455     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.9.1363     Document Type: Article

References (38)

1. Wiesner RH, Grambsch PM, Dickson ER et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10:430-6.
2. Farrant JM, Hayllar KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710-17.
3. Porayko MK, LaRusso NF, Wiesner RH. Primary sclerosing cholangitis: a progressive disease? Semin Liver Dis 1991;11:18-25.
4. Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis 1997;17:115-23.
5. Tjandra K, Sharkey KA, Swain MG. Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis. Hepatology 2000;31:280-90.
6. Ramierz F, Fowell DJ, Puklavec M, et al. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996;156:2406-12.
7. Daynes RA, Araneo BA, Dowell TA, et al. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 1990;171:979-96.
8. Daynes RA, Dudley DJ, Araneo BA. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 1990;20:793-802.
9. Swain MG, Maric M. Prevention of immune-mediated arthritis in cholestatic rats: involvement of endogenous glucocorticoids. Gastroenterology 1994;107:1469-74.
10. Madretsma GS, van Dijk APM, Wilson JHP, et al. Corticosteroid resistance in colitis is characterized by a low glucocorticoid receptor content of mononuclear cells. Gut 1995;37(suppl 2):A178.
11. Rogler G, Meinel A, Lingauer A, et al. Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononucrear cells from patients with inflammatory bowel disease. Eur J Clin Invest 1999;29:330-6.
12. Adcock IM, Lane SJ, Brown CR, et al. Differences in binding of glucocorticoid receptor to DNA in steroid- resistant asthma. J Immunol 1995;154:3500-5.
13. Syed F, Bingham B, Johnson M, et al. The CD4+ T lymphocyte is a site of steroid resistance in asthma. Q J Med 1998;91:567-72.
14. Mitchison HC, Bassendine MF, Malcolm AJ, et al. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology 1989;10:420-9.
15. van Hoogstraten HJ, Vleggaar FP, Bolond GJ, et al. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. Am J Gastroenterol 2000;95:2015-22.
16. Angulo P, Jorgensen RA, Keach JC, et al. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 2000;31:318-23.
17. Sarlis NJ, Chowdrey HS, Stephanou A, et al. Chronic activation of the hypothalamo- pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology 1992;130:1775-9.
18. Swain MG, Le T, Tigley AW, et al. Hypothalamic nitric oxide synthase is depressed in cholestatic rats. Am J Physiol 1997;272:G1034-40.
19. Swain MG, Appleyard C, Wallace J, et al. Endogenous glucocorticoids released during acute toxic liver injury enhance hepatic IL-10 synthesis and release. Am J Physiol 1999;276:G199-205.
20. Miller AH, Spencer RL, Pearce BD, et al. Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system. Cell Immunol 1998;186:45-54.
21. Lai KN, Leung J, CLai FM. Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T-lymphocytes in vitro. Pathology 1991;23:224-8.
22. Berguer R, Dalton M, Ferrick D. Adrenocortical response and regional T-lymphocyte activation patterns following minimally invasive surgery in a rat model. Surg Endosc 1998;12:236-40.
23. Xia M, Gasser J, Feige U. Dexamethasone enhances CTLA-4 expression during T cell activation. Cell Mol Life Sci 1999;55:1649-56.
24. Hata K, Zhang XR, Iwatsuki S, et al. Isolation, phenotyping, and functional analysis of lymphocytes from human liver. Clin Immunol Immunopathol 1990;56:401-19.
25. Franchimont D, Louis E, Dewe W, et al. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept 1998;73:59-65.
26. Quayle AJ, Chomarat P, Miossec P, et al. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 1993;38:75-82.
27. Benvenuto R, Paroli M, Buttinelli C, et al. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis. Clin Exp Immunol 1991;84:97-102.
28. Selmaj K, Raine CS, Cannella B, et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991;87:949-54.
29. Hearing SD, Norman M, Probert CS, et al. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 1999;45:382-8.
30. Straub RH, Vogl D, Gross V, et al. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am J Gastroenterol 1998;93:2197-202.
31. Hata K, Van Thiel DH, Herberman RB, et al. Natural killer activity of human liver- derived lymphocytes in various liver diseases. Hepatology 1991;14:495-503.
32. Seaman WE. Natural killer cells and natural killer T cells. Arthritis Rheum 2000;43:1204-17.
33. Schlaghecke R, Beuscher D, Kornely E, et al. Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do nat result in glucocorticoid resistance. Arthritis Rheum 1994;37:1127-31.
34. Oakley RH, Cidlowski JA. Homologous down regulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eukaryot Gene Expr 1993;3:63-88.
35. Kam JC, Szefler SJ, Surs W, et al. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993;151:3460-6.
36. Crabtree GR, Munck A, Smith KA. Glucocorticoids and lymphocytes. I. Increased glucocorticoid receptor levels in antigen-stimulated lymphocytes. J Immunol 1980;124:2430-5.
37. Smith KA, Crabtree GR, Kennedy SJ, et al. Glucocorticoid receptors and glucocorticoid sensitivity of mitogen stimulated and unstimulated human lymphocytes. Nature 1977;267:523-6.
38. Franchimont D, Martens H, Hagelstein MT, et al. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 1999;84:2834-9.